Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 3, 2008

Primary Completion Date

May 17, 2016

Study Completion Date

May 31, 2026

Conditions
Primary Central Nervous System Lymphoma
Interventions
RADIATION

cranial radiotherapy

40 Gy

DRUG

intensive chemotherapy and hematopoietic stem cell rescue

intensive chemotherapy and hematopoietic stem cell rescue

DRUG

MTX based chemotherapy

R-MBVP 2 cycles day1 and day28 followed by R-Aracytine 2 cycles days58\&59 and days79\&80

Trial Locations (23)

13009

CHU de la Timone, Marseille

33076

Institut Bergonié, Bordeaux

35033

Hôpital Pontchaillou, Rennes

38043

CHU Michalon, Grenoble

54500

CHU Nancy - Hôpital Neurologique, Vandœuvre-lès-Nancy

66046

CHG Saint Jean, Perpignan

75013

GH Pitié-Salpétrière, Paris

80054

Cancérologie Hôpital Sud, Amiens

86021

CHU Hôpital Bernard, Poitiers

87042

CHU de Limoges, Limoges

92210

Centre René Huguenin, Saint-Cloud

95100

CHR Argenteuil, Argenteuil

Unknown

Chu D'Angers, Angers

CHU de Besancon, Besançon

CHU Hôtel Dieu, Clermont-Ferrand

Centre Hospitalier Lens, Lens

Hôtel Dieu Nantes, Nantes

Centre Antoine Lacassagne, Nice

CHU de Nimes, Nîmes

Chu Reims, Reims

Institut de Cancérologie, Saint-Priest-en-Jarez

CH de Saint-Quentin, Saint-Quentin

Hôpital Bretonneau, Tours

Sponsors
All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Amgen

INDUSTRY

collaborator

Pierre Fabre Laboratories

INDUSTRY

lead

Institut Curie

OTHER